You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET-PTC5

Showing 1 - 25 of 636
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil

Recruiting
  • Colon Cancer
  • +4 more
  • 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2022

Epilepsy Trial in New York (ataluren, Placebo)

Completed
  • Epilepsy
  • New York, New York
    New York University School of Medicine
Sep 7, 2021

Acute Brain Injury Trial (TCM5 device (Radiometer) for PtC02 continuous measurement)

Not yet recruiting
  • Acute Brain Injury
  • TCM5 device (Radiometer) for PtC02 continuous measurement
  • (no location specified)
Mar 25, 2021

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

Recruiting
  • Medullary Thyroid Cancer
  • Birmingham, Alabama
  • +148 more
Jan 18, 2023

A Taiwanese Oncogenetic Panel and Integrated Clinical Data

Recruiting
  • Thyroid Cancer
  • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
  • Kaohsiung, Taiwan
  • +7 more
Sep 12, 2022

Phenylketonuria Trial in Worldwide (PTC923, Placebo)

Recruiting
  • Phenylketonuria
  • Stanford, California
  • +42 more
Nov 23, 2022

MDD Trial in Ames (Resistance Exercise Training)

Active, not recruiting
  • Major Depressive Disorder
  • Resistance Exercise Training
  • Ames, Iowa
    Iowa State University
Jan 12, 2023

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
Has Results
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

Phenylketonuria Trial in Worldwide (PTC923)

Recruiting
  • Phenylketonuria
  • Stanford, California
  • +42 more
Jun 23, 2022

NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Berazategui, Buenos Aires, Argentina
  • +195 more
Jan 30, 2023

Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

Active, not recruiting
  • Advanced Nonhaematologic Malignancies
  • Philadelphia, Pennsylvania
  • +20 more
Sep 23, 2022

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

Recruiting
  • Malignant Thyroid Gland Neoplasm
  • +6 more
  • Quality-of-Life Assessment
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jan 24, 2023

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Eyelid Dermatochalasis, Dermatochalasis Trial in Miami (Restorative Eye Treatment (RET) cream, INhance with Trihex Technology)

Active, not recruiting
  • Eyelid Dermatochalasis
  • Dermatochalasis
  • Restorative Eye Treatment (RET) cream
  • INhance with Trihex Technology
  • Miami, Florida
    Bascom Palmer Eye Institute, University of Miami
May 16, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022

Duchenne Muscular Dystrophy Trial in United States (Ataluren)

Completed
Has Results
  • Duchenne Muscular Dystrophy
  • Gulf Breeze, Florida
  • +5 more
Aug 12, 2020

NSCLC Trial in Guangzhou (HA121-28 tablet)

Recruiting
  • NSCLC
  • HA121-28 tablet
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Centre
Aug 2, 2022

ALK-positive NSCLC (NSCLC), RET-positive NSCLC (NSCLC), RET-positive Thyroid Cancer Trial in Irvine, Boston (Alectinib)

Terminated
Has Results
  • ALK-positive Non-small Cell Lung Cancer (NSCLC)
  • +2 more
  • Irvine, California
  • +3 more
Aug 30, 2021

Infected Immature Permanent Teeth Trial in Singapore (RET using antibiotics (Ciprofloxacin and Metronidazole), RET using

Completed
  • Infected Immature Permanent Teeth
  • RET using antibiotics (Ciprofloxacin and Metronidazole)
  • RET using non-setting Calcium Hydroxide
  • Singapore, Singapore
  • +1 more
Oct 13, 2021

Low-risk Papillary Thyroid Cancer, Endocrine Malignancy, Thyroid Cancer Trial run by the NCI (Total Thyroidectomy (TT),

Terminated
Has Results
  • Low-risk Papillary Thyroid Cancer
  • +2 more
  • Total Thyroidectomy (TT)
  • Prophylactic central neck lymph node dissection (pCND)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 8, 2022